Brief: Embecta Q2 Revenue USD 287.2 Million
09/05/2024 11:30
May 09 (Reuters) - Embecta Q2 adjusted EBITDA USD 90.8 million. * Q2 adjusted gross profit USD 185.8 million * Q2 dividend USD 0.15 * Q2 adjusted operating income USD 74.9 million * Q2 operating income USD 39.2 million * Q2 gross profit USD 185.4 million
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel